BMY Competitors & Alternatives
Compare Bristol-Myers Squibb Company with similar stocks in the same industry
Drug Manufacturers - General
BMY
Main Stock$63.00
Tradestie Score
44
Market Cap
$96.54B
P/E Ratio
13.6
Revenue Growth
0.1%
Analyst Upside
+3.8%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABT
Abbott Laboratories
|
$102.51
|
$232.30B | 33.6 | 50 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.24
|
$225.13B | 117.7 | 43 | Compare |
|
AMGN
Amgen Inc
|
$447.28
|
$160.70B | 27.3 | 35 | Compare |
|
PFE
Pfizer Inc.
|
$30.42
|
$154.70B | 39.6 | 35 | Compare |
|
GILD
Gilead Sciences Inc
|
$157.19
|
$137.92B | - | 43 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.96
|
$121.27B | 21.8 | 59 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$51.21
|
$91.59B | 16.0 | 37 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$253.84
|
$22.61B | 43.2 | 39 | Compare |
|
GRFS
Grifois, S.A.
|
$7.45
|
$6.78B | 9.8 | 52 | Compare |
|
OGN
Organon & Co.
|
$13.75
|
$2.86B | 17.6 | 49 | Compare |
More BMY Analysis
Data updated: Oct 22, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry